课题基金 / 基金详情

CD11b Antibody Fragments as PET Imaging Probes for Glioma-Associated Myeloid Cells

CD11b Antibody Fragments as PET Imaging Probes for Glioma-Associated Myeloid Cells
CD11b 抗体片段作为胶质瘤相关骨髓细胞的 PET 成像探针
批准号:
9751856
负责人:
Wilson Barry Edwards
金额:
$23.42万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2020-05-31

项目摘要

项目成果

Wilson Barry Edwards的其他基金

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
ABSTRACT Average survival times for glioblastoma patients remain around 15 months because of relatively few effective treatments. CD11b+ Tumor-associated myeloid cells, can account for up to 40% of the tumor mass, are well known to suppress anti-tumor immunity, and directly promote tumor growth. While significant advances have been made in the development of TAMC-targeted therapies, analysis of TAMCs requires analysis of surgically resected tumor tissue. In this R21 application we propose that development of a novel tracer, Cu-64 labeled antibody fragments, which will allow for non-invasive PET imaging of TAMCs in glioblastomas. We will therefore, test our novel hypothesis that Cu-64-labeled monobodies or diabodies derived from the m1/70 hybridoma will enable quantification TAMC infiltration into the tumor and monitoring of TAMC-targeted immunotherapies. We will first generate and test the sensitivity of our antibody fragments following injections of varying concentrations of CD11b+ mouse spleenocytes from C57BL/6j mice into CD11b-knockout C57BL/6j- background syngeneic glioma-bearing mice (Aim 1). We will then demonstrate that our novel antibody fragments can be used to monitor TAMC-targeted therapies including anti-Gr1-antibody, Celecoxib, or a CSF-1R inhibitor in the GL261 syngeneic glioma model, and a de novo glioma model (AIM 2). As the m1/70 clone can recognize both human and mouse CD11b, we believe that our preclinical studies can lead to quick translation of our findings into TAMC-targeted clinical trials in patients with glioblastoma, or in patients with other neuroinflammatory disorders. !
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
Engineered Antibodies as PET Probes for Monitoring Immunotherapy Responses
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
海外基金